Complement C5 inhibitor as a rescue therapy for acute NMOSD attacks: a multicenter retrospective cohort study in China. Wu T, Tian D, Huang D, Wu L, Zhen J, Yin J, Guo J, Jiang J, Li F, Jin H, et al. Front Immunol. 2026; 17:1917016. PMID: 42812414. Abstract CommentRecommendBookmarkWatch